Timing of Energy Availability on Menstrual Cycle Function

NCT ID: NCT06471582

Last Updated: 2025-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-01

Study Completion Date

2027-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary aim of this clinical trial is to evaluate how fasted prolonged exercise may influence circulating reproductive hormones (i.e., estradiol, progesterone, luteinizing hormone) and menstrual cycle length when energy availability is maintained at or above 30 kcal/kg lean body mass/ day among women who regularly do running or cycling exercise. A secondary aim is to determine the effects of fasted prolonged exercise on serum leptin and cortisol.

Participants will be asked to do the following over a \~3 month enrollment period:

* attend a laboratory visit at the beginning of the study to have their resting metabolic rate, aerobic fitness, and body composition tested
* monitor their menstrual cycle length, urine hormones, perceived stress levels, and diet for \~3 months
* complete 3, 90-minute exercise sessions on a stationary bike or treadmill either fed (consuming a carbohydrate meal 1 h prior and 0.7 g carbohydrate/ kg body mass/ h during exercise) or fasted (consuming no meal prior and no carbohydrates during exercise) during month \~3
* saliva samples will be taken prior to and after 90-minute exercise sessions for quantification of leptin and cortisol

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menstrual Irregularity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fed with Carbohydrates

Participants will complete 3, 90-minute stationary cycle or treadmill exercise sessions 1 h after consuming a meal containing 1 g carbohydrate/ kg body weight. During exercise, they will consume an artificially sweetened beverage containing 0.7 g carbohydrate/ kg body mass/ h as a 2:1 mixture of glucose and fructose.

Group Type EXPERIMENTAL

Artificially Sweetened Carbohydrate Beverage

Intervention Type DIETARY_SUPPLEMENT

Beverage containing 0.7 g carbohydrate/ kg body mass/ h as a 2:1 mixture of glucose and fructose and artificial sweetener

Fasted without Carbohydrates

Participants will complete 3, 90-minute stationary cycle or treadmill exercise sessions following an overnight fast. During exercise, they will consume an artificially sweetened beverage containing no carbohydrates.

Group Type PLACEBO_COMPARATOR

Artificially Sweetened Beverage

Intervention Type DIETARY_SUPPLEMENT

Beverage containing no carbohydrates or kilocalories and an artificial sweetener

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Artificially Sweetened Carbohydrate Beverage

Beverage containing 0.7 g carbohydrate/ kg body mass/ h as a 2:1 mixture of glucose and fructose and artificial sweetener

Intervention Type DIETARY_SUPPLEMENT

Artificially Sweetened Beverage

Beverage containing no carbohydrates or kilocalories and an artificial sweetener

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* participates in structured running or cycling exercise for at least 30 minutes on 3 or more days per week
* accustomed to exercising for 90 minutes or more
* has regular periods every 21-35 days
* have not taken hormonal contraceptives for at least the past 6 months
* is not currently or trying to become pregnant or breastfeeding, and has not been pregnant or breastfeeding in the past 12 months
* does not currently have a diagnosis of a major menstrual cycle disorder (i.e., amenorrhea, polycystic ovary syndrome \[PCOS\], endometriosis, ovarian cancer, ovarian insufficiency, uterine or endometrial cancer)
* does not currently have a metabolic disease (i.e., hypothyroidism, hyperthyroidism, Cushing disease, Addison's disease, diabetes, congenital adrenal hyperplasia)
* does not currently have a major cardiovascular or respiratory disease

Exclusion Criteria

* miss more than 7 consecutive days of aerobic activity (i.e., running, cycling, cross training)
* demonstrate clinical low energy availability as defined as energy availability \<30 kcal/kg fat free mass
* report menstrual cycle lengths \<21 or \>35 days in the first 2 months of at-home monitoring
* do not demonstrate an anticipated rise in luteinizing hormone and progesterone in the first 2 months of at-home monitoring
* begin taking a hormonal contraceptive
* become pregnant
* are diagnosed with a menstrual cycle disorder (i.e., amenorrhea, polycystic ovary syndrome \[PCOS\], endometriosis, ovarian cancer, ovarian insufficiency, uterine, or endometrial cancer)
* are diagnosed with a metabolic disease (i.e., hypothyroidism, hyperthyroidism, Cushing disease, Addison's disease, diabetes)
* are diagnosed with a major cardiovascular or respiratory disease
* are unable to follow instructions for any of the procedures
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Colorado, Colorado Springs

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marissa Baranauskas

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

William J. Hybl Sports Medicine and Performance Center

Colorado Springs, Colorado, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marissa Baranauskas, PhD

Role: CONTACT

719-255-4475

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marissa Baranauskas, PhD

Role: primary

719-255-4475

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FAST

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.